These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33839143)

  • 1. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.
    Langley MR; Ghaisas S; Palanisamy BN; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Exp Neurol; 2021 Jul; 341():113716. PubMed ID: 33839143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
    Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
    Langley M; Ghosh A; Charli A; Sarkar S; Ay M; Luo J; Zielonka J; Brenza T; Bennett B; Jin H; Ghaisas S; Schlichtmann B; Kim D; Anantharam V; Kanthasamy A; Narasimhan B; Kalyanaraman B; Kanthasamy AG
    Antioxid Redox Signal; 2017 Nov; 27(14):1048-1066. PubMed ID: 28375739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
    Fifel K; Cooper HM
    Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease.
    Li X; Redus L; Chen C; Martinez PA; Strong R; Li S; O'Connor JC
    PLoS One; 2013; 8(8):e71341. PubMed ID: 23977020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.
    Ay M; Luo J; Langley M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    J Neurochem; 2017 Jun; 141(5):766-782. PubMed ID: 28376279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
    Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Bäckman CM; Larsson NG; Olson L; Gellhaar S; Galter D; Lupica CR
    FASEB J; 2011 Apr; 25(4):1333-44. PubMed ID: 21233488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
    Ekstrand MI; Galter D
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rodent models of Parkinson's disease.
    Harvey BK; Wang Y; Hoffer BJ
    Acta Neurochir Suppl; 2008; 101():89-92. PubMed ID: 18642640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease.
    Cong L; Muir ER; Chen C; Qian Y; Liu J; Biju KC; Clark RA; Li S; Duong TQ
    PLoS One; 2016; 11(3):e0151884. PubMed ID: 27003179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
    Beckstead MJ; Howell RD
    Exp Neurol; 2021 Jul; 341():113707. PubMed ID: 33753138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.
    Taylor TN; Caudle WM; Shepherd KR; Noorian A; Jackson CR; Iuvone PM; Weinshenker D; Greene JG; Miller GW
    J Neurosci; 2009 Jun; 29(25):8103-13. PubMed ID: 19553450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.
    Galter D; Pernold K; Yoshitake T; Lindqvist E; Hoffer B; Kehr J; Larsson NG; Olson L
    Genes Brain Behav; 2010 Mar; 9(2):173-81. PubMed ID: 20002202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT
    Lim J; Bang Y; Choi JH; Han A; Kwon MS; Liu KH; Choi HJ
    J Neurosci; 2018 Feb; 38(7):1611-1621. PubMed ID: 29305532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.
    Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ
    Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
    Kao CY; Xu M; Wang L; Lin SC; Lee HJ; Duraine L; Bellen HJ; Goldstein DS; Tsai SY; Tsai MJ
    PLoS Genet; 2020 Jun; 16(6):e1008868. PubMed ID: 32579581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L; Sun F; Huang R; Sun W; Zhang D; Wang Q
    Redox Biol; 2019 Apr; 22():101134. PubMed ID: 30798073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models.
    Clement A; Mitchelmore C; Andersson DR; Asuni AA
    Neuroscience; 2017 Jun; 354():101-109. PubMed ID: 28461218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.